Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence

The global tissue diagnostics market is projected to grow from USD 6.45 billion in 2025 to USD 9.33 billion by 2031, with a CAGR of 6.35%. Growth is driven by increasing cancer prevalence, rising adoption of precision medicine, advancements in digital pathology and AI-assisted diagnostics, and expanding biomarker-based testing. North America leads the market while Asia-Pacific emerges as a high-growth region.

05/21/2026, 3:37 AM • GlobeNewswire

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight

The cervical cancer diagnostics market is projected to grow from USD 4.4 billion in 2025 to USD 7.1 billion by 2034 at a CAGR of ~5%. Growth is driven by rising cervical cancer prevalence, increasing adoption of advanced diagnostic technologies like HPV testing and AI-powered screening tools, government screening initiatives, and expanding healthcare infrastructure particularly in emerging economies. North America leads the market with 44% share in 2025.

05/14/2026, 1:00 PM • GlobeNewswire

Pregnancy Detection Kits Market Analysis Report 2026 - Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031

The global pregnancy detection kits market is projected to grow from USD 1.91 billion in 2025 to USD 2.69 billion by 2031, with a CAGR of 5.87%. Growth is driven by technological advancements enabling earlier detection, rising infertility rates, and increasing adoption of digital integration and e-commerce distribution. However, the market faces challenges from accuracy concerns and user error risks that erode consumer trust.

05/08/2026, 4:47 AM • GlobeNewswire

Danaher Announces Quarterly Dividend

Danaher Corporation announced that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share, payable on July 31, 2026 to shareholders of record on June 26, 2026.

05/05/2026, 4:30 PM • Benzinga

Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight

The plasmid DNA manufacturing market is projected to grow from USD 2.4 billion in 2025 to USD 10.8 billion by 2034, driven by rising demand for gene therapies, DNA vaccines, and CAR-T treatments. North America leads the market with 44.12% share, while Asia-Pacific emerges as a significant growth engine. Major companies are expanding GMP-compliant manufacturing capabilities to meet increasing demand from biopharmaceutical companies and CDMOs.

05/04/2026, 1:00 PM • GlobeNewswire

Why Medtech Giants Are Quietly Paying Up for AI Diagnostics

The global AI in medical imaging market is experiencing rapid growth with a projected $2.20 billion valuation in 2026 and 34.8% CAGR through 2033. Major medtech companies including Danaher, Medtronic, DexCom, and Profound Medical are making strategic acquisitions and expanding AI-powered diagnostic platforms. Hospitals are increasingly prioritizing AI clinical solutions, with 57% ranking them as top technology priorities in 2026-2027, driving demand for validated platforms with real clinical evidence.

04/29/2026, 10:30 AM • Benzinga

[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global cell culture media bags market is valued at USD 1.30 billion in 2025 and is projected to reach USD 2.28 billion by 2035, growing at a CAGR of 5.8%. Growth is driven by increased R&D investments in life sciences, adoption of single-use bioprocessing technologies, and automation trends in biopharmaceutical manufacturing. Single-use bags and EVA materials dominate the market segments, with North America leading in market share and Asia Pacific showing the highest growth rate.

04/29/2026, 12:30 AM • GlobeNewswire

Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031

The global bulk filtration market is experiencing significant expansion driven by stringent environmental regulations, industrialization, and demand for clean air and water. Key growth drivers include adoption of smart filtration technologies with IoT and AI integration, self-cleaning systems, and advanced membrane filtration methods. The market is expected to grow through 2031 with major players focusing on innovation and sustainability across industries including pharmaceuticals, food and beverage, chemicals, and water treatment.

04/28/2026, 10:00 AM • GlobeNewswire

This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline?

Danaher, a leading life sciences company, has underperformed over the past five years due to post-pandemic normalization and weak China sales, but shows signs of recovery with revenue growth resuming in mid-2024. The company's $9.9 billion acquisition of Masimo, a pulse oximetry leader, is expected to add significant revenue and EBITDA. Trading at a 22x P/E ratio—well below its historical 32x average—Danaher presents a potential buying opportunity for long-term investors.

04/24/2026, 2:15 PM • The Motley Fool

Coagulation Analyzer Market Size to Reach a Valuation of USD 7.87 Billion by 2035; Increasing Incidence of Blood Disorders to Propel Market Expansion Globally | SNS Insider

The global coagulation analyzer market is projected to grow from USD 4.60 billion in 2025 to USD 7.87 billion by 2035, with a CAGR of 5.55%. Growth is driven by rising blood disorders, increasing surgeries, automation in diagnostics, and cardiovascular disease prevalence. The U.S. market alone is expected to grow from USD 1.50 billion to USD 2.41 billion. Consumables dominate with 64.28% market share, while fully automated systems show the fastest growth at 6.48% CAGR. Hospitals lead end-user segment with 52.84% share, and Asia-Pacific is the fastest-growing region at 7.24% CAGR.

04/22/2026, 10:00 AM • GlobeNewswire

Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - Global Forecast to 2031

The global allergy diagnostic market is expected to grow from USD 6.80 billion in 2025 to USD 10.77 billion by 2030, at a CAGR of 9.6%. Growth is driven by technological innovations such as multiplex immunoassays and molecular allergology, rising allergy incidence, and increasing awareness. North America leads the market, with major players including Thermo Fisher Scientific, Siemens Healthineers, and Danaher Corporation dominating the competitive landscape.

04/13/2026, 8:00 AM • GlobeNewswire

Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision Medicine

The global NGS market is projected to reach USD 29.53 billion by 2030 from USD 14.94 billion in 2025, growing at a CAGR of 14.6%. Growth is driven by expanding applications in oncology, infectious diseases, and precision medicine, with Asia-Pacific exhibiting the fastest regional growth. Consumables dominate the product segment, while academic and research institutes lead the services end-user segment.

04/10/2026, 5:45 AM • GlobeNewswire

Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider

The global molecular diagnostics market is projected to grow from USD 18.26 billion in 2025 to USD 43.50 billion by 2035, with a CAGR of 9.07%. Growth is driven by increasing demand for early and accurate disease detection, rising prevalence of chronic diseases, and adoption of advanced technologies like PCR and next-generation sequencing. The U.S. market is expected to grow from USD 5.0 billion to USD 8.07 billion during the same period.

04/03/2026, 5:00 AM • GlobeNewswire

Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence

The global drug screening market is projected to reach USD 20.86 billion by 2031, growing at a CAGR of 16.16%. Chromatography and mass spectrometry technologies dominated with 44.77% market share in 2025. Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure and workplace safety initiatives. Market growth is fueled by increasing adoption across workplaces, healthcare settings, and law enforcement, alongside technological advancements in point-of-care testing and rapid detection devices.

04/03/2026, 3:15 AM • GlobeNewswire

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

The global Pharmaceutical Microbiology QC Testing Market is projected to grow from USD 5.08 billion in 2025 to USD 17.65 billion by 2035, at a CAGR of 13.27%. Growth is driven by increased regulatory oversight, laboratory automation, antimicrobial resistance concerns, and adoption of advanced technologies like AI-enabled molecular platforms and MALDI-TOF mass spectrometry. North America leads with 39.12% market share, while Asia Pacific is expected to grow fastest at 14.33% CAGR.

03/10/2026, 2:00 PM • GlobeNewswire